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T-cells recognize lipid antigens presented by dedicated antigen-presenting molecules that
belong to the CD1 family.This review discusses the structural properties of CD1 molecules,
the nature of mycobacterial lipid antigens, and the phenotypic and functional properties of
T-cells recognizing mycobacterial lipids. In humans, the five CD1 genes encode structurally
similar glycoproteins that recycle in and thus survey different cellular endosomal compart-
ments. The structure of the CD1-lipid-binding pockets, their mode of intracellular recycling
and the type of CD1-expressing antigen-presenting cells all contribute to diversify lipid
immunogenicity and presentation toT-cells. Mycobacteria produce a large variety of lipids,
which form stable complexes with CD1 molecules and stimulate specificT-cells.The struc-
tures of antigenic lipids may be greatly different from each other and each lipid may induce
unique T-cells capable of discriminating small lipid structural changes. The important func-
tions of some lipid antigens within mycobacterial cells prevent the generation of negative
mutants capable of escaping this type of immune response.T-cells specific for lipid antigens
are stimulated in tuberculosis and exert protective functions. The mechanisms of antigen
recognition, the type of effector functions and the mode of lipid-specific T-cell priming are
discussed, emphasizing recent evidence of the roles of lipid-specificT-cells in tuberculosis.
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INTRODUCTION
The discovery that T lymphocytes recognize lipid molecules as
antigens (1) was a breakthrough in cellular immunology that
opened unexpected horizons in the field of immune response to
microbes, to cancer cells, and in autoimmunity.
Despite main structural differences with peptide antigens, lipid
antigens are presented to T-cells following general rules that closely
resemble those implicated in the presentation of peptide anti-
gens. Indeed, only lipids forming stable complexes with dedicated
antigen-presenting molecules, which belong to the CD1 protein
family (2), are capable of interacting with the T-cell receptor (TCR)
and may induce the activation of specific T-cells.
Many different types of lipids behave as antigens capable of
stimulating specific T-cells and Mycobacterium tuberculosis is the
bacterium with the largest number of antigenic lipids identified so
far. Mycobacteria are characterized by a complex cellular envelope
composed of a variety of unique lipids (3), which have impor-
tant functions in survival of mycobacterial bacilli (4). Envelope
lipids are also implicated in tissue-specific replication (5) and con-
trolled penetration of engulfing cells (6) and in escaping immune
response with different mechanisms (7). Therefore, Mycobacteria
are reluctant in changing the lipid composition of their envelope.
Mycobacterial lipids, glycolipids, and lipopeptides may bind to
and form stable complexes with different CD1 molecules, and may
interact with specific TCR.
The generation of stable CD1–lipid antigen complexes mostly
occurs within the infected cell and follows a series of well coordi-
nated events. These include the transport of lipid antigens by lipid
chaperones in cellular membranes and endosomal compartments,
the extraction of lipids from membranes, their processing, and
subsequent insertion in the hydrophobic pockets of CD1 mole-
cules. Stable CD1–lipid complexes are then routed to the plasma
membrane where they become available for T-cell recognition (8).
Mycobacteria have evolved a series of tactics to interfere with
lipid antigen presentation, showing the surprising capacity of
inhibiting and hijacking different protective immune mecha-
nisms. The existence of these evasion strategies is the indirect
evidence that lipid-specific immune response represents an impor-
tant mechanism of defense in tuberculosis. How lipid-specific
T-cells participate in controlling mycobacterial infections is an
important field of investigation in many laboratories that is pro-
viding new information on protective immune mechanisms and
is suggesting novel approaches to vaccine development.
This chapter describes the nature, structure, and function of
mycobacterial lipid antigens, the mechanisms of their recognition
by T-cells, the biological properties of CD1 antigen-presenting
molecules and the rules that govern presentation of lipids to T-
cells. The relevance of lipid-specific T-cells in tuberculosis is also
discussed.
CD1 ANTIGEN-PRESENTING MOLECULES
In humans five genes encode different CD1 isoforms, which are
classified into three families (group 1, 2, and 3). CD1a, b, and c
molecules belong to the group 1 family, whereas CD1d and CD1e
are the only members of group 2 and 3, respectively. The separa-
tion into three families follows important structural differences,
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cellular and tissue distribution of each CD1 protein. CD1a, b, and
c are expressed on CD4, CD8 double positive thymocytes, and
on peripheral antigen-presenting cells (APC), including dendritic
cells (DC), monocytes, and a subset of B cells. Each of these mol-
ecules can be uniquely expressed. For example, CD1a, but not
CD1b and c are expressed by Langerhans cells in the skin and
represent a marker distinguishing this cell population. CD1b is
expressed by a population of monocytes and is upregulated dur-
ing differentiation into DC. CD1c is expressed on a large fraction
of human B cells. CD1d is instead more extensively expressed on
both hematopoietic and non-hematopoietic cells.
CD1e is the only CD1 protein that is not expressed on the
plasma membrane and remains confined within the Golgi complex
and late endosomes/lysosomes. All CD1 molecules are expressed
by professional APC such as DC.
The structures of all CD1 molecules have been solved and
showed important differences that illustrate their unique antigen-
binding capacities.
STRUCTURE OF CD1 MOLECULES AND REPERTOIRE OF
PRESENTED LIPID ANTIGENS
CD1 molecules have structures similar to those of MHC class I
molecules. They are glycoproteins composed of a heavy chain non-
covalently associated with β2-microglobulin. The heavy chain is
made of three domains. The α1 and α2 domains, which assem-
ble together in the membrane distal part of the molecule, are
characterized by two anti-parallel α helices positioned above a
β sheet plate. The α3 domain instead is membrane-proximal and
associates with β2-microglobulin. It also continues with the trans-
membrane domain and a short intracytoplasmic tail. Each CD1
molecule shows a portal located in between the α1 and α2 helices,
which allows access to two to four pockets. The pockets are sur-
rounded by hydrophobic amino acids, thus representing ideal
places to allocate the apolar alkyl chains of lipid antigens.
CD1a
Each CD1 molecule shows unique structural features.
CD1a has one portal located between the two α helices, which is
connected with two pockets, called A′ and F′ (a nomenclature sim-
ilar to that of MHC molecules). Around the portal a few charged
amino acids stabilize and properly orient the antigen headgroup
for TCR recognition. The F′ pocket has an incomplete roof thus
being partially open on the surface of CD1a. The mode of lipid-
binding of CD1a is unique, since the open F′ pocket permits ready
insertion and replacement of lipid antigens. This feature opti-
mally complements another unique characteristics of CD1a, i.e.,
its recycling through early endosomal stations (9, 10). Early endo-
somal compartments are slightly acidic environments that do not
induce main conformational changes to the structure of recycling
proteins. In addition, lipid transfer proteins that facilitate lipid
antigen loading on CD1 molecules are localized in other endoso-
mal compartments. Therefore, an open F′ pocket seems a natural
evolution of CD1a to facilitate otherwise unfavorable conditions
for loading of lipid antigens.
The co-crystal of CD1a with lipid antigens have also provided
important information on another consequence of the unique
open F′ pocket structure.
The CD1a-sulfatide structure revealed that the sphingosine
occupies the A′ pocket whereas the fatty acid chain protrudes in
the interface of the A′ and F′ pockets. The headgroup of sulfatide,
made by a galactose and a sulfate is anchored in the A′–F′ junction
and partially occupies the upper part of the F′ pocket in a position
ideally suited for TCR recognition (11).
The crystal structure of CD1a with lipopeptide dideoxymy-
cobactin (DDM) instead showed that while the single alkyl chain
was inserted deep within the A′ pocket, the two peptidic moieties
of the antigen were lying partially in the F′ pocket and at the surface
of CD1a, an optimal position for recognition by the TCR (12).
MYCOBACTERIAL LIPID ANTIGENS PRESENTED BY CD1a
The overall size of CD1a grove is limited to 1350 Å3, thus preclud-
ing binding of lipid antigens of large size. So far, only DDM has
been identified as mycobacterial antigen presented by CD1a (13).
Dideoxymycobactin is the precursor of mycobactin, a
siderophore with iron scavenging properties. The structure of
DDM shows a complex head group made of unusual amino acids
synthesized by non-ribosomal mycobacterial enzymes. The lysine
of headgroup is linked to a single alkyl chain, which is 20 carbons
long. One clone specific for CD1a–DDM was isolated and when
it was tested the length and saturation of the DDM alkyl chain
appeared very important for T-cell stimulation. This behavior was
fully explained by the structural resolution of the CD1a–DDM
complex, which showed a deep insertion of the acyl chain in the
CD1a A′ pocket. As this pocket is closed at one end, the inser-
tion of too short or too long acyl chains determines a different
positioning of the peptidic residues, thus directly influencing the
interaction with the TCR. This mode of binding led the authors to
discuss a role as a ruler of the A′ CD1a pocket (12). During their
intracellular growth, mycobacteria increase mycobactin synthesis
to increase their capacity of iron capture. Thus presentation of
DDM may be an efficient mechanism to identify cells harboring
living mycobacteria.
CD1b
The molecule CD1b is expressed by activated monocytes and DC.
CD1b presents most of the identified mycobacterial antigens and
follows unique recycling and lipid loading rules. Within the group
1 CD1 family, CD1b has the largest pocket (~2200 Å3) and is made
by four interconnected pockets, which confer unique lipid antigen-
binding properties. A large portal is located between the two α
helices that is connected with the A′, C′, and F′ pockets. The A′
pocket continues into the F′ pocket through a tunnel called T′
pocket. The combination of the four pockets with the large size,
allows CD1b to bind lipid antigens with very long alkyl chains, such
as the mycobacterial mycolyl chains that can reach a length of 80
carbons. The structure of CD1b has been solved thus revealing
how CD1b can accommodate either very long or short lipid anti-
gens (14–17). Mycolic acid (MA), an antigen with long alkyl chain
that can contain up to 80 carbons occupies the A′, T′, and F′ pock-
ets, whereas the mycobacterial diacylated sulfoglycolipids (SGL)
occupy the A′ and C′ pockets with their two alkyl chains. This
flexibility in lipid-binding raised the question of why the CD1b
T′ pocket does not collapse when antigens with short alkyl chains
are bound. The reason for this stability was found when a soluble
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CD1b molecule produced in eukaryotic cells and physiologically
refolded in vivo was crystallized. This molecule showed the pres-
ence of different spacers within the T′ pocket, thus representing a
filling lipid preventing the collapse of the molecule (18).
MYCOBACTERIAL LIPID ANTIGENS PRESENTED BY CD1b
Mycolic acids were the first antigens, which were identified as lipids
capable of stimulating specific T-cells (19). These long and highly
hydrophobic lipids represent very important components of the
cell wall of several bacteria, including Mycobacteria, Corynebac-
teria, and Nocardia. MA are unique fatty acids of high-molecular-
weight, with α-alkyl, β-hydroxyl groups. They may be present as
such or as bound esters of sugars like arabinogalactan and tre-
halose. Activation assays using different types of MA, showed
that the hydroxyl and carboxyl groups may represent important
structural features sensed by T-cells (19).
Mycolic acid may also be considered as scaffold molecules that
form stimulatory antigen when attached to other molecules. For
example, glucose monomycolate (GMM) is capable of stimulat-
ing specific T-cells (20). In GMM, a glucose residue is attached
to MA and is critical for T-cell recognition as the stereoisomers
mannose- or galactose-monomycolate are not or poorly stimula-
tory. T-cells also discriminate the type of glycosidic bond, as GMM
with glucose bound with 6-hydroxyl to MA is stimulatory, whereas
glucose-3-monomycolate is not stimulatory (21).
Another antigen with modified MA is glycerol monomycolate
(GroMM) (22) that is made of a glycerol moiety attached to a
MA and is also produced by Mycobacteria, Corynebacteria, and
Nocardia. The glycerol hydroxyl moiety and the fatty acid length
of GroMM influence T-cell response. MA-related lipids are pre-
sented only by CD1b as this is the only CD1 molecule with an
open T′ pocket allowing the insertion of long fatty acids.
A second family of lipid antigens presented by CD1b is those
sharing a phosphatidyl-myo-inositol (PI). Phosphatidylinositol
mannoside (PIM) and lipoarabinomannan (LAM) are two lipid
antigens presented by CD1b (23). LAM and PIM share a core
region, where the mannoses linked to PI are the stimulatory anti-
gens. LAM contains a terminal part with many arabinoses in some
instances capped with mannoses. Lipomannan (LM), which is
similar to LAM, but does not contain arabinose, can also stimu-
late specific T-cells (23). T-cells discriminate lipoglycans made in
different bacteria. T-cells recognizing LAM from Mycobacterium
leprae, do not recognize LAM from M. tuberculosis (23). These
LAM differ in the number and branching points of mannoses
present in the core that are probably involved in interacting with
the TCR.
All lipoglycans are too big to allocate within the CD1b pockets
and interact with T-cells. They require internalization and process-
ing in late endosomes (24). PIM6, which is the hexamannosylated
form of PIM, also requires processing with shortening of the
hexamannoses in order to stimulate specific T-cells (25). Another
aspect that is not clear yet is whether these antigens also require
processing by lipases. Indeed naturally occurring PIM is charac-
terized by four alkyl chains and they need ad hoc cleavage before
forming stable complexes with CD1b (our unpublished data).
A third family of CD1b-presented lipid antigens is that of
SGL (26). SGL are localized in the outer part of cell envelope
and their abundance was associated with strain virulence (27),
although mutant strains revealed that sulfolipid deficiency does
not significantly affect the replication, persistence, and path-
ogenicity of M. tuberculosis H37Rv in mice and guinea pigs
or in cultured macrophages (28). SGL contain a trehalose 2′
sulfate core, acylated by two to four fatty acids. This anti-
gen isolated from virulent mycobacteria strains proved to a
be a mixture of structurally related diacylated SGL (Ac2SGL)
containing hydroxyphtioceranoic and palmitic or stearic acid,
both linked to the glucose without the sulfate in the trehalose.
The tri- and tetra-acylated forms were not immunogenic, thus
revealing that APC do not have the proper lipase apparatus to
digest these forms and generate the diacylated immunogenic
forms. Removal of the sulfate group completely abolished T-
cell activation (26), suggesting that the fine antigen specificity
of the TCR is also influenced by the strong negative charges of
sulfate.
The structure of CD1b–SGL complex has been solved and
showed a unique mode of interaction of this lipid antigen with the
CD1b (17). Comparison of the CD1b crystals with and without
SGL showed that upon antigen-binding, the endogenous spacers
of CD1b, which consist of a mixture of diradylglycerols, move
considerably within the lipid-binding groove. Spacer displace-
ment was accompanied by F′ pocket closure and an extensive
rearrangement of residues exposed to T-cell receptors. Such struc-
tural reorganization resulted in reduction of the A′ pocket capacity
and led to incomplete embedding of the methyl-ramified portion
of the phthioceranoyl chain of the antigen, explaining why such
hydrophobic motifs are critical for T-cell receptor recognition.
Mutagenesis experiments supported the functional importance of
the observed structural alterations for T-cell stimulation. Thus,
CD1b is a very plastic molecule, capable of important structural
rearrangements that combine spacer repositioning and ligand-
induced conformational changes. Both these changes endow CD1b
with the capacity to present a broad range of structurally diverse
antigens and to focus the TCR only on the antigen-filled CD1b
molecules.
CD1c
The CD1c molecule is characterized by unique features that
contribute to the important biological features of this CD1 isotype.
The central portal located in between the two alpha helices
allows protrusion of the hydrophilic moiety of bound antigen,
which is presumably involved also in contacting the TCR. This
portal is connected with the A′ and F′ pockets. The A′ pocket
may accommodate the alkyl chain of bound antigen (29). The
A′ pocket is open to the external part of CD1c with an exit por-
tal located underneath the α1 helix. Interestingly, the F′ pocket
of CD1c showed an open cavity, which is similar to the antigen-
binding groove of MHC-peptide-binding molecules and in some
respects to the F′ pocket of CD1a. The F′ pocket is also open to
the exterior with a second portal called E′. Whether these addi-
tional portals facilitate binding of very long alkyl chains, remains
unclear, although this type of antigen interaction is energetically
unfavorable.
CD1c is also characterized by a unique type of intracellu-
lar recycling. It may recycle in deep endosomal compartments,
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where low pH may facilitate partial CD1 unfolding and anti-
gen loading. Furthermore, in these compartments dedicated lipid
antigen-binding proteins (LBP) are present, which behave as lipid
chaperones and are involved in lipid antigen-binding, transport,
and loading on CD1 molecules. This mode of antigen loading
resembles that of lipids on CD1b and CD1d. In addition, some
CD1c molecules recycle through the early endosomal compart-
ments, where the most acidic pH is 6.5 and probably no LBP are
present. In this cellular compartment, the partially open structure
of the F′ pocket might facilitate antigen exchange and binding.
MYCOBACTERIAL LIPID ANTIGENS PRESENTED BY CD1c
Both the unique portals and structure of the F′ pocket explain
the promiscuous antigen-binding behavior of CD1c. This mole-
cule may present lipid antigens containing one alkyl chain (30),
two alkyl chains (31), or lipopeptides formed by one alkyl chain
linked to a short peptide (32). Furthermore, CD1c stimulates a
population of T-cells expressing the gamma and delta chains of
the TCR (TCR γδ) (33, 34). As the described CD1c-restricted TCR
γδ cells are autoreactive, it is very probable that CD1c presents a
self-antigen, which remains unknown.
Recently, we have identified the novel self lipid methyl-
lysophosphatidic acids (mLPA), not described before, which accu-
mulates in myeloid and lymphoid leukemia cells and induces a
CD1c-restricted response directed against these human leukemias
(35). mLPA-specific T-cells efficiently kill CD1c+ acute leukemia
cells, and protect immunodeficient mice against CD1c+ human
leukemia cells and poorly recognize non-transformed CD1c-
expressing cells. Whether similar types of lipids are produced by
mycobacteria or accumulate in infected cells during mycobacterial
infection and induce CD1-restricted T-cell responses is matter of
current investigation.
Mannosyl β-1-phosphomycoketides (MPM) were the first
CD1c-restricted lipid antigens (30). MPM contain a single fully
saturated alkyl chain with methyl branches at every fourth car-
bon. MPM are synthesized by Mycobacteria infecting human
cells, including M. tuberculosis, BCG, and Mycobacterium avium,
and not by rapidly growing saprophytes, including Mycobacterium
phlei, Mycobacterium fallax, and Mycobacterium smegmatis (36).
The structure of MPM is similar to that of phosphodolichols
that in mammalian cells function as carbohydrate donors in gly-
can synthesis. However, differently from phosphodolichols they
are not synthesized through an isoprenoid-independent pathway.
Instead, the synthesis of MPM is accomplished by the enzyme
Pks12 and requires the sequential condensation of malonate and
methylmalonate units. Probably, these polyketides are involved
in bacterial intracellular growth and in mannose transmembrane
transport, according to their structural similarity with eukaryotic
phosphodolichols. As found with other glycolipid-specific T-cells,
also MPM-specific T-cell recognition is sensitive to structural
changes in the hydrophilic and hydrophobic parts of MPM. Anti-
gen recognition occurs when glucose and not mannose is present.
Furthermore, the saturated α-prenyl like unit and the length of
the prenyl chain are important for recognition. Moreover, vari-
ation in the number, length, and saturation of alkyl chains, and
the precise chemistry and chirality of the lipid head group, also
exert dominant influences on antigenicity (30, 36, 37), probably
by affecting the mode of CD1 binding and interaction with the
TCR (38).
CD1d
Like other CD1 molecules, also CD1d contains antigen-binding
pockets, which are much deeper than the groove of peptide-
binding MHC molecules. The two pockets are constituted by
a non-polar or hydrophobic surface. The pockets converge in a
portal open on the surface of CD1d and located in between the
two anti-parallel helices. A series of TCR–CD1d–lipid antigen co-
crystals have shown the importance of the polar antigen residues,
which provide minimal but essential interactions with the TCR
(39–42).
The A′ pocket of CD1d is closed and allows the insertion of
alkyl chains with a defined length. In the presence of lipid antigens
with too short alkyl chains, small fatty acids may also be present,
which contribute to filling the entire A′ pocket probably behaving
as rulers preventing CD1d collapse (43).
CD1d is expressed on mostly all hematopoietic cells. It is also
present on the surface of gut epithelial cells, adipocytes, and some
keratinocytes. Most of the cells retain a large fraction of properly
assembled CD1d in late endosomes and lysosomes, in a manner
similar to that of MHC class II molecules. Upon synthesis, CD1d
rapidly traffics to the plasma membrane and then initiates a fast
intracellular recycling. A fraction of CD1d molecules is assembled
together with the invariant chain that promotes a direct traffic to
late endosomes (44). The mode of intracellular trafficking of CD1d
is dependent on the unique intracytoplasmic tail that facilitates the
interaction with the AP3 proteins (45). Indeed, this association is
necessary to properly load lipid antigens intracellularly (46).
Many microorganisms modulate surface CD1d, including M.
tuberculosis. Several studies have outlines different modulation
capabilities according to the type of cell, the triggered surface
receptor, and the possible involvement of soluble factors. While
several viruses, including vaccinia, herpes simplex, hepatitis, and
lymphocytic choriomeningitis viruses decrease CD1d expression
in myeloid cells (47–49), infections with Salmonella typhimurium
or E. coli increase the plasma membrane display of CD1d (50). M.
tuberculosis infection or mycobacterial lipids also upregulate CD1d
on bone-marrow-derived macrophages (51). Instead M. tubercu-
losis infection prevents the upregulation of CD1d in monocytes
that differentiate to DC (52, 53).
MYCOBACTERIAL LIPID ANTIGENS PRESENTED BY CD1d
CD1d-restricted T-cells are classified in two major groups. The
most widely investigated are invariant natural killer T (iNKT)
cells, which express an invariant human Vα24Jα18 or mouse
Vα14Jα18 TCR chain. These cells recognize with high affin-
ity the α-galactosylceramide (αGalCer) lipid extracted from
the marine sponge Agelas mauritianus (54). iNKT cells are
highly conserved in many species, thus suggesting that they
exert important immunological functions conserved during evo-
lution. iNKT cells also recognize other non-microbial anti-
gens, including phosphatidylinositol (PI), phosphatidylglycerol
(PG), and phosphatidylethanolamine (PE), although with a
weak affinity compared to the strong agonist αGalCer (55).
Lysophosphatidylcholine, a lipid generated by lipid-dependent
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signaling pathways, may also stimulate iNKT cells (56). Other
CD1d-presented antigens are the ether-bonded mono-alkyl glyc-
erophosphates that together with the precursors and degradation
products of plasmalogens are required for the proper selection and
maturation of iNKT cells in the thymus (57).
Very initial studies suggested that a tetramannosylated PIM
form (PIM4) present in a fraction of lipids purified from Mycobac-
terium bovis BCG was a potential CD1d-presented iNKT cell anti-
gen (58). These findings have not been confirmed in subsequent
studies and the potential role of PIM4 as CD1d-presented antigen
to iNKT cells still awaits confirmation. While CD1d mycobac-
terial antigens have not been identified so far, other bacteria
produce strong iNKT stimulatory lipids, including the glycolipids
with diacylglycerol moieties of Borrelia burgdorferi and Strepto-
coccus pneumoniae (59, 60), and the glycosphingolipids present in
the cell walls of bacteria belonging to the genera Sphingomonas
and Novosphingobium (61). Surface glycophospholipids of the
protozoal parasites Leishmania species are also iNKT stimula-
tory antigens (62). iNKT-deficient mice are more susceptible to
Leishmania infection, indicating that iNKT cells have important
functions in protection. However, it is still unknown how Leishma-
nia lipophosphoglycan (LPG) stimulate these T-cells. While LPG
binds to CD1d,CD1d–LPG complexes do not stimulate iNKT cells.
DC pulsed with LPG can induce IFNγ release by iNKT cells, sug-
gesting that LPG stimulates the production of endogenous lipid
ligands, which in turn activate iNKT cells. This is not a remote pos-
sibility, since bacterial infections may induce important changes
in the lipid metabolism of infected cells. This, in turn, may induce
accumulation of endogenous lipids that stimulate T-cells restricted
by either group 1 or group 2 CD1 molecules (63–65).
A second group of CD1d-restricted T-cells utilized non-
invariant TCR and resemble other T-cells involved in classi-
cal adaptive immune responses. These T-cells recognize PG,
diphosphatidylglycerol (DPG or cardiolipin), and PI from M.
tuberculosis or Corynebacterium glutamicum as microbial anti-
gens (66). Importantly, the same lipid molecules are present
also in mammalian cells and thus they represent self-antigens.
Thereby, the increased availability of these self-antigens within
APC might also contribute to the activation of CD1d-restricted
T-cells cross-reactive with microbial antigens.
CD1e
CD1e is a unique type of CD1 molecule as it remains intracellular
and therefore cannot be considered a bona fide antigen-presenting
molecule (67). CD1e is mostly expressed by DC where it accu-
mulates in the Golgi stack of immature cells as pre-protein (68).
Upon maturation, CD1e is ubiquitinated (69) and traffics to the
lysosomes where it is cleaved in two places. In the amino-terminal
region a propeptide is cleaved, that is responsible for the assembly
of CD1e with β2-microglobulin. Upon its removal CD1e becomes
fully active (70). CD1e is also cleaved in its membrane-proximal
region, thus becoming a mature soluble protein. CD1e is appar-
ently not secreted and does not accumulate in other intracellular
compartments. These features make CD1e similar to the HLA-
DM and HLA-DO molecules, which are also not expressed on
the plasma membrane of APC. The acid pH of lysosomes pro-
motes a partial alteration of CD1e structure together with the
binding of lipid antigens through increased hydrophobic and ionic
interactions (71).
The crystal structure of CD1e revealed a groove less intricate
than in other CD1 proteins, with a significantly wider portal. The
water-exposed CD1e groove probably allows loose contacts with
lipid antigens as supported by the finding that lipid association and
dissociation processes were faster with CD1e than with CD1b (72).
All these structural features support the function of CD1e as a
LBP with the exquisite capability of facilitating lipid antigen pre-
sentation by other CD1 molecules. Indeed, CD1e mediates in vitro
the transfer of lipids to CD1b and the displacement of lipids from
stable CD1b-antigen complexes (72). CD1e is also required for the
proper processing of complex mycobacterial lipid antigens such as
the PIM6 molecules. In the presence of CD1e, PIM6 is cleaved
to PIM2 and is loaded on CD1b (25). CD1e may also positively
or negatively affect lipid presentation by CD1b, CD1c, and CD1d
(73). This effect is achieved by a rapid formation of CD1–lipid
complexes in the presence of CD1e, and also by an accelerated
turnover of formed CD1–lipid antigen complexes. These effects
maximize and temporally narrow CD1-restricted responses. CD1e
is therefore an important modulator of both group 1 and group 2
CD1-restricted responses influencing the lipid antigen availability
as well as the generation and persistence of CD1–lipid complexes.
T-CELLS RECOGNIZING MYCOBACTERIAL LIPID ANTIGENS
T-cells stimulated by lipid antigens are divided into two categories
according to their functional behavior and mechanism of antigen
recognition. T-cells restricted by group 1 CD1 molecules and type
II NKT cells are considered as arm of adaptive T-cell responses,
while CD1d-restricted type II NKT or iNKT cells are considered
as the typical representative of innate T-cell responses.
Lipid-specific T-cells that are restricted by group 1 CD1 mol-
ecules are present as naïve T-cells and expand after encountering
the antigen, mostly during mycobacterial infections or BCG vac-
cination (26). They expand and may also differentiate into clas-
sical memory T-cells (74). These studies have been performed
using human samples, as small rodents do not express group 1
CD1 molecules. Upon antigen recognition, lipid-specific T-cells
release pro-inflammatory cytokines and may also kill intracellular
Mycobacteria, thus participating in host protection (26). They also
induce maturation of DC (75), thus facilitating priming of other
mycobacteria-specific T-cells.
The TCR repertoire of lipid-specific T-cells is polymorphic and
there is no evidence of unique TCR V genes imposing the recog-
nition of antigens presented by CD1a, CD1b, or CD1c. There is
also no evidence that type II NKT cells utilize a restricted TCR
repertoire. Recently, using CD1b tetramers loaded with GMM,
a rare population of T-cells was identified, which uses a nearly
invariant TCR (76). These T-cells were defined as mycolyl lipid-
reactive (GEM) cells. The TCR of these GMM-specific and CD1b-
restricted T-cells is constituted by a TRAV1.2 gene rearranged to
TRAJ19 segment. Furthermore, these T-cells showed a strong bias
for usage of TRB6-2 gene and high affinity for the CD1b–GMM
complex. The analysis of nucleotides in the CDR3 of the Vα chain
showed that similar CDR3 amino acids were derived from dif-
ferent patterns of exonucleolytic trimming of the V and J regions,
suggesting an antigen recognition-induced mechanism driving the
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expansion of these cells. This conclusion was also supported by the
finding of identical nucleotide sequences in GMM-specific T-cells.
In addition, the same sequences were found several times in the
same donors, indicating in vivo expansion of GEM T-cells. A sec-
ond study also showed that CD1b–GMM tetramers may identify
another population of T-cells, using the TRAV17 and TRBV4-1
genes, which is present in several donors, has intermediate affinity
for the CD1b–GMM complexes and shows biased but different
CDR3 motifs (77). Whether this second population is expanded
in donors with active or latent tuberculosis remains to be defined.
The identification of lipid-specific T-cells has made an incred-
ible technical jump by using the tetrameric forms of soluble CD1
molecules loaded with lipid antigens. In addition to the CD1b
tetramers that have been discussed above,also CD1c (78) tetramers
have been generated. With the use of these tetramers it was pos-
sible to identify a population of CD1c-restricted and mycoketide-
specific T-cells that use a polyclonal TCR repertoire. The identifica-
tion of CD1-restricted T-cells using antigen-loaded CD1 tetramers
has important implications, since detection of lipid-specific T-cells
might represent a novel approach to monitor the T-cell response
in patients with active or latent forms of tuberculosis.
An important set of data indicates that group 1 CD1-restricted
T-cells have important functions in animal models and in humans.
Immunization of guinea pigs (Cavia porcellus), a species
expressing multiple CD1b and CD1c gene orthologs, induces
strong proliferative and cytotoxic responses restricted by CD1b
and CD1c (79, 80) and immunization with total M. tuberculosis
lipids induced a significant reduction of lung lesions (81).
Cattle (Bos taurus) are sensitive to natural infection with
M. bovis, causing bovine tuberculosis that shares many clinical
and pathological characteristics with human tuberculosis. Poly-
clonal T-cells isolated from naturally infected animals showed
specific response to challenge with lipids from M. bovis and
M. avium paratuberculosis (82). Uninfected animals immunized
with GMM also developed GMM-specific CD1b-restricted T-cells,
which persisted 4 months after the last immunization (83).
Studies performed in CD1 transgenic mice showed lipid-
specific T-cells upon immunization with M. tuberculosis lipids or
infected with M. tuberculosis (84).
Several studies investigated the response of human T-cells to
stimulation with mycobacterial lipids ex vivo. Using this approach,
T-cells specific for the mycobacterial antigens GroMM (22), GMM
(85), SGL (26), MA (74), and MPM (30) were identified. In sev-
eral cases, these T-cells were detected only in tuberculosis patients
and not in healthy individuals, indicating that priming with lipid
antigens occurs during infection.
A series of important immunological questions on the role
of lipid-specific T-cells in tuberculosis remain to be answered.
Firstly, most of the studies were performed with established T-cell
clones using different cellular assays including cell proliferation,
IFNγ release, and cell cytotoxicity. These assays detect protec-
tive anti-microbial capacities and indicate potential anti-microbial
protective effects of these cells. These studies should be comple-
mented with the functional analysis of T-cells freshly isolated
from tuberculosis patients and possibly by in vivo studies using
CD1 transgenic mice. Secondly, the mechanisms of lipid-specific
T-cell memory generation remain unknown. The experimental
data showing absence of mycobacterial lipid-specific T-cells in
non-infected individuals supports that naïve T-cells are primed by
a specific antigen and expand in vivo. Whether these cells persist
for a long period of time and rapidly expand upon challenge with
the antigen is not clear. These issues are of paramount impor-
tance to understand the possible use of lipid antigens as novel
sub-unit anti-mycobacterial vaccines. Thirdly, the tissue-specific
expression of CD1 proteins might represent a limitation to the
protective activity of CD1-restricted T-cells. Macrophages are the
cells harboring Mycobacteria during infection and do not express
detectable levels of CD1 molecules. Therefore, these cells might
be invisible to lipid-specific T-cells, thus reducing their potential
protective role. Another important issue is whether CD1-restricted
T-cells massively migrate to infected tissues, mostly the lung, and
therefore are rare in circulating blood. The accumulation of lipid-
specific T-cells in the lung of tuberculosis patients has not been
properly investigated yet.
The second population of lipid-specific T-cells is represented by
iNKT cells, which are innate-like T-cells. These cells are constantly
activated by a variety of self- and microbial antigens and show a
phenotype of pre-activate cells. They contain in their cytoplasm
preformed cytokines mRNA, including IFNγ mRNA. They readily
secrete these cytokines upon antigen recognition at levels that are
up to 200-fold higher than those of naïve peptide-specific T-cells
(86, 87). They also rapidly induce DC maturation, which in turn
facilitates priming of CD8+ cytotoxic T-cells (88). Considering
that this latter T-cell population is relevant in protection during
mycobacterial infections (89), iNKT cell engagement might be also
important for protection.
In vivo studies conducted in mice also showed that iNKT are
activated during mycobacterial infections. Following BCG infec-
tion, there is an increase of iNKT cells in the lung that show signs of
activation (90). iNKT cells were assumed to be important in devel-
opment of lung granuloma following infection (90–92). Instead
a series of studies performed using CD1d-deficient mice (lack-
ing all types of CD1d-restricted T-cells) or Jα18-deficient animals
(lacking mainly iNKT cells), did not show relevant difference in the
mycobacterial colony forming units in the lung, nor in the survival
of infected animals as compared to wild type mice (93–96).
Overall these studies showed that iNKT cells do not have an
impact on chronic infection in mice and suggest that they are
not involved in direct protective roles during tuberculosis. Thus,
the potentially protective functions of iNKT cells, if any, may be
present only in the early acute phases of microbial infections and be
neglectable in the natural course of prolonged chronic infections
such as tuberculosis.
Studies conducted in humans are observational and are limited
to the numbers, phenotype, and ex vivo function of iNKT cells
isolated from peripheral blood. None of these investigations sup-
ported an important role of iNKT cells in tuberculosis, although
reduction in their number and phenotype has been observed in
patients with active tuberculosis (97–99).
CONCLUSION
From the overview of the studies reported here, there are increas-
ing evidences of the relevance of the immune response elicited by
mycobacterial lipids. The identification of lipid molecules essential
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for bacterial virulence together with the absence of functional CD1
polymorphisms is the basis for vaccine development. There is
therefore increasing hope that the inclusion of lipid antigens in
new vaccine formulations would lead to a successful vaccination
against tuberculosis.
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